KLRD1
KLRD1, also known as CD94, is a C-type lectin superfamily membrane protein preferentially expressed on natural killer (NK) cells. It is thought to take part in regulating NK cell function, and the KLRD1 gene is also called killer cell lectin like receptor D1. Browse Assay Genie's current range of KLRD1 research reagents below, or read on for the biology behind the target.
NK cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in regulating NK cell function. KLRD1 (CD94) is one such antigen, and it is preferentially expressed on NK cells. In the context of SARS-CoV-2 infection, the UniProt annotation notes that KLRD1 may contribute to functional exhaustion of cytotoxic NK cells and CD8-positive T cells. On NK cells it may recognise HLA-E in complex with a SARS-CoV-2 Spike S1-derived peptide (LQPRTFLL) displayed on lung epithelial cells, which can induce NK cell exhaustion and dampen antiviral immune surveillance.
The KLRD1 protein is localised to the cell membrane and is classified as a type II membrane protein, meaning it has an external C terminus. Several transcript variants encoding different isoforms have been reported for the KLRD1 gene, so researchers studying expression should consider which variants their approach detects. Orthologous genes, both named Klrd1, are present in mouse and rat, which allows comparative work in rodent models.
HGNC places KLRD1 in the groups of CD molecules, killer cell lectin like receptors and C-type lectin domain containing proteins. Its previous name was killer cell lectin-like receptor subfamily D, member 1, and CD94 remains a widely used alias in the literature and in the naming of a KLRD1 antibody or other reagents.
KLRD1 is preferentially expressed on NK cells, a lymphocyte lineage that mediates cytotoxicity and cytokine secretion, making it a useful marker for studying NK function.
As a C-type lectin superfamily member alongside the NKG2 family, KLRD1 may be involved in regulating NK cell function.
KLRD1 may recognise HLA-E presenting a Spike-derived peptide and contribute to exhaustion of cytotoxic NK and CD8-positive T cells.
KLRD1 is a type II membrane protein with several transcript variants encoding different isoforms, relevant to expression and splicing analysis.
KLRD1 (CD94) is a cell membrane antigen preferentially expressed on NK cells and is thought to be involved in regulating NK cell function. During SARS-CoV-2 infection it may recognise HLA-E bound to a Spike-derived peptide, contributing to NK and CD8-positive T cell exhaustion.
KLRD1 is also known as CD94 and as Natural killer cells antigen CD94 in UniProt. Its HGNC name is killer cell lectin like receptor D1, previously killer cell lectin-like receptor subfamily D, member 1. Several transcript variants encode different isoforms.
Yes. Mouse and rat both have an ortholog named Klrd1, so rodent models can be used to study this NK cell receptor. Cross-species use depends on the reagent, so check the datasheet of any product for its validated reactivity.
Other NK cell receptors, NKG2 family members and immune surveillance markers with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13241; product specifications from Assay Genie datasheets.